An Integrative Approach to Diagnose Heparin-Induced Thrombocytopenia: Development, Validation, and Implementation of a Multivariable Prediction Model

July 12, 2022 | Michael Nagler, M.D., Ph.D., M.Sc., Inselspital University Hospital and University of Bern, Bern, Switzerland

FRONTIER1: A Phase 1/2 Dose Escalation Study of a Novel Factor VIIIa Mimetic Bispecific Antibody, Mim8, for Evaluation of Safety, Pharmacokinetics and Efficacy

July 11, 2022 | Pratima Chowdary, M.D., F.R.C.Path., Royal Free Hospital, London, United Kingdom